Marcus Bernardini, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study.
Frontiers in oncology · 2022
Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline
Hereditary Cancer in Clinical Practice · 2021
The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma.
Gynecologic oncology · 2016

All 4 publications

Latest funding

Precise point-of-care testing devices for diagnosis and prognosis of ovarian cancer
CIHR · 2021 · Co-investigator
$317,476
The Ovarian Cancer Glycoproteome: Biomarker Discovery and Therapeutic Targets
CIHR · 2020 · Co-investigator
$504,901
Porphyrin Nanomedicine for Cancer Imaging and Therapy
CIHR · 2016 · Co-investigator
$3,300,088

All 8 grants and awards

4 publications.

01

18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study.

Metser U, Kulanthaivelu R, Chawla T, Johnson S, Avery L, Hussey D, Veit-Haibach P, Bernardini M, Hogen L

Frontiers in oncology20225 citationsOpen Access

DOI: 10.3389/fonc.2022.1025475 PMID: 36313720

02

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline

Jacobson M, Coakley N, Bernardini M, Branco K-A, Elit L, Ferguson S, Kim R

Hereditary Cancer in Clinical Practice202112 citationsOpen Access

DOI: 10.1186/s13053-021-00196-9 PMID: W3204480707

03

The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma.

Hogen L, Thomas G, Bernardini M, Bassiouny D, Brar H, Gien LT, Rosen B, Le L, Vicus D

Gynecologic oncology201635 citations

DOI: 10.1016/j.ygyno.2016.09.006 PMID: 27623251

04

The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.

Rosen B, Laframboise S, Ferguson S, Dodge J, Bernardini M, Murphy J, Segev Y, Sun P, Narod SA

Gynecologic oncology2014118 citations

DOI: 10.1016/j.ygyno.2014.07.004 PMID: 25026637

Precise point-of-care testing devices for diagnosis and prognosis of ovarian cancer

Co-investigatorCIHR2021Project Grant

Principal investigators: Thompson, Michael

Keywords: Cancer Diagnostic Device; Cancer Prognostic Device; Electrochemical Biosensor; Ovarian Cancer; Point-Of-Care Testing Device

$317,476

The Ovarian Cancer Glycoproteome: Biomarker Discovery and Therapeutic Targets

Co-investigatorCIHR2020Project Grant

Principal investigators: Kislinger, Thomas

Keywords: Biomarker; Cancer Spheroids; Cell Surface; Crispr-Cas9; Glycoprotein; High-Grade Serous Ovarian Cancer; Proteomics

$504,901

Porphyrin Nanomedicine for Cancer Imaging and Therapy

Co-investigatorCIHR2016Foundation Grant

Principal investigators: Zheng, Gang

Keywords: Blood Brain Barrier; Cancer Imaging; Image-Guided Therapy; Immunotherapy; Lipoprotein; Microbubbles; Nanoparticle; Photodynamic Therapy; Photothermal Therapy; Radiotherapy

$3,300,088

Clinical evaluative studies in hereditary breast and ovarian cancer

Co-investigatorCIHR2016Foundation Grant

Principal investigators: Narod, Steven A

Keywords: Brca1; Brca2; Breast Cancer; Genetics; Genomics; Ovarian Cancer; Prevention

$1,952,885

Functional and Molecular Characterization of Cancer-Associated Fibroblasts in High Grade Serous Ovarian Cancer

Co-investigatorCIHR2016Project Grant

Principal investigators: Ailles, Laurie E

Keywords: Cancer-Associated Fibroblasts; Epigenetics; High Grade Serous Ovarian Cancer; Patient-Derived Xenografts; Pharmacogenomics

$698,445

Validation of subtype-specific ovarian cancer biomarkers for pelvic mass discrimination

Co-investigatorCIHR2016Op Grant: Analyses of Existing Canadian Cohorts & Databases - Cancer Control

Principal investigators: Kulasingam, Vathany

Keywords: Biomarkers; Immunoassays; Mass Spectrometry; Omics Technology; Ovarian Cancer; Pelvic Mass

$75,000

Sustained ovulation-associated inflammatory signaling in fallopian tube epithelium as a predisposing factor of serous carcinoma

Co-investigatorCIHR2013Operating Grant

Principal investigators: Brown, Theodore J; Rosen, Barry P

Keywords: Fallopian Tube; Glucocorticoid; Inflammation; Molecular Biology; Ovarian Cancer; Ovulation; Serous Cancer

$483,754

A Novel Biomarker Discovery Strategy Combining Primary Tumour Xenograft Models and Glyco-Capture of Secreted Proteins

Co-investigatorCIHR2013Operating Grant

Principal investigators: Kislinger, Thomas

Keywords: Biomarker; Ovarian Cancer; Proteomics; Recurrence; Xenograft

$351,553

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Obstetrics & Gynaecology
Department of Medical Imaging
Obstetrics & Gynecology
Department of Medicine
Epidemiology Division

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.